These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 24577515

  • 1. Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.
    Cheng D, Low JK, Logge W, Garner B, Karl T.
    Psychopharmacology (Berl); 2014 Aug; 231(15):3009-17. PubMed ID: 24577515
    [Abstract] [Full Text] [Related]

  • 2. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
    Cheng D, Spiro AS, Jenner AM, Garner B, Karl T.
    J Alzheimers Dis; 2014 Aug; 42(4):1383-96. PubMed ID: 25024347
    [Abstract] [Full Text] [Related]

  • 3. Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice.
    Watt G, Shang K, Zieba J, Olaya J, Li H, Garner B, Karl T.
    J Alzheimers Dis; 2020 Aug; 74(3):937-950. PubMed ID: 32116258
    [Abstract] [Full Text] [Related]

  • 4. Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice.
    Cheng D, Low JK, Logge W, Garner B, Karl T.
    Behav Brain Res; 2014 Mar 01; 260():111-8. PubMed ID: 24315833
    [Abstract] [Full Text] [Related]

  • 5. Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice.
    Coles M, Watt G, Kreilaus F, Karl T.
    Front Pharmacol; 2020 Mar 01; 11():587604. PubMed ID: 33424597
    [Abstract] [Full Text] [Related]

  • 6. Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice.
    Watt G, Chesworth R, Przybyla M, Ittner A, Garner B, Ittner LM, Karl T.
    Pharmacol Biochem Behav; 2020 Sep 01; 196():172970. PubMed ID: 32562718
    [Abstract] [Full Text] [Related]

  • 7. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W.
    Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse model.
    Chesworth R, Cheng D, Staub C, Karl T.
    Front Pharmacol; 2022 Sep 15; 13():931384. PubMed ID: 36238565
    [Abstract] [Full Text] [Related]

  • 9. Novel behavioural characteristics of the APP(Swe)/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
    Cheng D, Logge W, Low JK, Garner B, Karl T.
    Behav Brain Res; 2013 May 15; 245():120-7. PubMed ID: 23419740
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice.
    Kreilaus F, Przybyla M, Ittner L, Karl T.
    Behav Brain Res; 2022 May 03; 425():113812. PubMed ID: 35202719
    [Abstract] [Full Text] [Related]

  • 11. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J, Sinclair D, Sebree T, Bonn-Miller M, Gutterman D, Siegel S, Karl T.
    Pharmacol Biochem Behav; 2019 Jun 03; 181():93-100. PubMed ID: 31063743
    [Abstract] [Full Text] [Related]

  • 12. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.
    J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    Aso E, Andrés-Benito P, Carmona M, Maldonado R, Ferrer I.
    J Alzheimers Dis; 2016 Sep 01; 51(2):489-500. PubMed ID: 26890764
    [Abstract] [Full Text] [Related]

  • 14. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 15. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A, Dudonné S, Bourassa P, Bourdoulous M, Tremblay C, Desjardins Y, Calon F, Neurophenols consortium.
    J Alzheimers Dis; 2017 Sep 23; 55(1):115-135. PubMed ID: 27662290
    [Abstract] [Full Text] [Related]

  • 16. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J, Giménez-Llort L, Valero J, Miñano A, Rábano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA.
    Biol Psychiatry; 2010 Mar 15; 67(6):513-21. PubMed ID: 19664757
    [Abstract] [Full Text] [Related]

  • 17. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L.
    Pharmacol Biochem Behav; 2012 Jan 15; 100(3):361-9. PubMed ID: 21993310
    [Abstract] [Full Text] [Related]

  • 18. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.
    Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 20. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ, Ip SP, Yuan QJ, Zheng GQ, Tsim KKW, Dong TTX, Lin G, Han Y, Liu Y, Xian YF, Lin ZX.
    Brain Behav Immun; 2019 Nov 15; 82():264-278. PubMed ID: 31476414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.